"Closer to Truth brings together leading
scientists, scholars and artists to debate the
fundamental issues of our times. Instituted in
the sixties, clinical drug trials today have
become a vast and expensive enterprise in which
drug companies can spend over $100 million to
bring a new molecule to market. FDA procedures
are complex and elaborate as they should be, in
order to bring new drugs to market quickly to
help people in need, but to do good science to
protect the public from a drug's potentially
dangerous side effects. Joining Robert Kuhn are Alexander Capron,
Professor of Law and Medicine, USC; Andrea Kovacs, Director, HIV
Family Clinic, USC; and Robert Temple, Associate Director, Medical
Policy, FDA."
Tags: Alexander Capron, Andrea Kovacs, Closer to Truth, drugs, FDA, Robert Kuhn, Robert Temple
Leave a Reply
You must be logged in to post a comment.
